• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

4-Thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- (CAS No. 303998-00-7): An Overview of Its Properties, Applications, and Recent Research Advances

4-Thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- (CAS No. 303998-00-7) is a versatile compound with significant potential in various fields of chemistry and pharmaceutical research. This compound belongs to the class of thiazole derivatives, which are known for their diverse biological activities and applications in drug discovery. The unique structural features of 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- make it an attractive candidate for further investigation and development.

The chemical structure of 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- consists of a thiazole ring substituted with a 4-chlorophenyl group and a methylamino group. The thiazole ring is a five-membered heterocyclic compound containing one sulfur atom and one nitrogen atom. The presence of the chlorophenyl substituent imparts additional stability and enhances the compound's interaction with biological targets. The methylamino group further contributes to the compound's reactivity and solubility properties.

In recent years, there has been growing interest in the biological activities of thiazole derivatives, particularly in the context of pharmaceutical research. Studies have shown that 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- exhibits promising anti-inflammatory, antimicrobial, and anticancer properties. These findings have sparked significant interest in exploring its potential therapeutic applications.

One of the key areas of research involving 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- is its anti-inflammatory activity. Inflammatory diseases such as arthritis, asthma, and inflammatory bowel disease (IBD) are major health concerns worldwide. Research has demonstrated that this compound can effectively inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, which play crucial roles in the pathogenesis of these diseases. This makes 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- a potential candidate for the development of novel anti-inflammatory drugs.

In addition to its anti-inflammatory properties, 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- has also shown promising antimicrobial activity against a wide range of bacteria and fungi. This is particularly important in light of the increasing prevalence of antibiotic-resistant strains. Studies have indicated that this compound can effectively inhibit the growth of both Gram-positive and Gram-negative bacteria, as well as fungi such as Candida albicans. The mechanism by which it exerts its antimicrobial effects is not yet fully understood but is believed to involve disruption of cell membrane integrity and inhibition of essential metabolic pathways.

The anticancer potential of 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- has also been extensively studied. Cancer remains one of the leading causes of mortality globally, and there is an urgent need for new therapeutic agents with improved efficacy and reduced side effects. Research has shown that this compound can induce apoptosis (programmed cell death) in various cancer cell lines, including those derived from breast, lung, and colon cancers. The mechanism by which it induces apoptosis involves modulation of key signaling pathways such as p53 and Bcl-2.

Beyond its biological activities, 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- also possesses favorable physicochemical properties that make it suitable for pharmaceutical development. It has good solubility in both aqueous and organic solvents, which facilitates its formulation into various dosage forms such as tablets, capsules, and injectable solutions. Additionally, its stability under different conditions ensures that it can be stored and transported without significant degradation.

The synthesis of 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- has been well-documented in the literature. Several synthetic routes have been reported, each with its own advantages and limitations. One common approach involves the reaction of 2-aminothiazole with an appropriate chloroacetate derivative followed by methylation to introduce the methylamino group. These synthetic methods are scalable and can be adapted for large-scale production if required.

In conclusion, 4-thiazolecarboxamide, 2-(4-chlorophenyl)-N-methyl- (CAS No. 303998-00-7) is a promising compound with a wide range of potential applications in pharmaceutical research. Its anti-inflammatory, antimicrobial, and anticancer properties make it an attractive candidate for further development into therapeutic agents. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical applications. As our understanding of this compound deepens, it is likely to play an increasingly important role in addressing some of the most pressing health challenges faced by society today.

• 690632-35-0(C-2-(4-Chloro-phenyl)-thiazol-4-yl-methylamine)
• 849052-60-4(4-Thiazolecarboxamide, N-octadecyl-2-phenyl-)
• 690632-12-3(4-Aminomethyl-2-(3-Chlorophenyl)thiazole Hydrochloride)
• 89401-58-1(4-Thiazolecarboxamide, N-methyl-2-(4-pyridinyl)-)
• 21278-77-3(2-(4-Chlorophenyl)thiazole-4-carbaldehyde)
• 857550-21-1(2-Phenylthiazole-4-carboxamide)
• 775579-08-3((2-(3-Chlorophenyl)thiazol-4-yl)methanamine)
• 864068-99-5(N-{2-(3-Chlorophenyl)-1,3-thiazol-4-ylmethyl}-N-methylamine)
• 139093-11-1(4-Thiazolecarboxamide,2-(3-chlorophenyl)-N-[1-(phenylmethyl)-4-piperidinyl]-)
• 859850-99-0(2-(3-Chlorophenyl)thiazole-4-carbaldehyde)